ITGAM and neoplasm: Interestingly, and in contrast to results from the tumour microenvironment, a significant increase in VISTA+ CD11b+ myeloid cells was observed in DLNs for oleuropein, SFV-αPD1, and oleuropein/SFV-αPD-1 treated groups (Fig. 6m).